Tag: 1

AS LHV Group’s May financial results reflected positive performance, with the results of all subsidiaries in line with the financial plan. LHV Group earned a consolidated net profit of EUR 9.1 million in May, with return on equity attributable to shareholders of 14.1%. Among the subsidiaries, AS LHV Pank earned EUR 9.8 million, LHV Bank Ltd EUR 0.3 million, AS LHV Varahaldus EUR 0.2 million and AS LHV Kindlustus EUR 0.4 million in net profit.

Montreal, Canada, June 16, 2026 (GLOBE NEWSWIRE) --  UFC lightweight contender Arman Tsarukyan has scored a massive payday on the Jack betting platform, turning a $1 million wager into a huge $5.7 million payout after Justin Gaethje defeated Ilia Topuria.

SINGAPORE, June 16, 2026 /PRNewswire/ -- Today, Arcfra announces the release of Arcfra Kubernetes Engine (AKE) version 1.6, the latest version of its production-grade container management...

Handcrafted in San Francisco, the Gramercy Leather Sling offers a full-grain leather alternative to the technical fabric crossbody bags that dominate compact everyday carry....

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

Rhode Island Becomes Zum's 18th State as Company Expands Northeast PresenceREDWOOD CITY, Calif., June 15, 2026 /PRNewswire/ -- Scituate School Department and Johnston Public...

MHB018A demonstrated outstanding clinical activity in both active and chronic thyroid eye diseaseAt 450 mg Q4W, MHB018A achieved a remarkable 81% proptosis response at...

New collaboration provides framework between the Japan government and ItalyTOKYO, June 15, 2026 /PRNewswire/ -- Rapidus Corporation today announced that it signed a Memorandum of...

SYDNEY, June 15, 2026 /PRNewswire/ -- Bifox Limited ("Bifox") is pleased to advise it has entered into two agreements with Fossal S.A.A ("Fossal"), to...

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”), of the important June 23, 2026 lead plaintiff deadline.

TAIPEI, June 15, 2026 /PRNewswire/ -- ACON OPTICS (TWSE: 6820), a leading provider of advanced optical connectivity solutions, showcased its latest innovations in AI...

AI strategies automatically execute trades, with XRP settling daily on time, completely eliminating the need for manual monitoring.

AI strategies automatically execute trades, with XRP settling daily on time, completely eliminating the need for manual monitoring.